J Otolaryngol Ophthalmol Shandong Univ ›› 2018, Vol. 32 ›› Issue (4): 58-61.doi: 10.6040/j.issn.1673-3770.0.2017.068

Previous Articles     Next Articles

Clinical analysis of low-grade myofibroblastic sarcoma of the head and neck

BAI Yong1, YIN Yingchun2, HAN Xuefeng1, YIN Zhaofu1, LI Xuezhong3   

  1. Department of Pathology, Zibo Central Hospital, Zibo 255000, Shandong, China;3. Department of Otorhinolaryngology, Qilu Hospital of Shandong University, NHC Key Laboratory of Otorhinolaryngology(Shandong University), Jinan 250012, Shandong, China
  • Received:2017-02-16 Online:2018-07-20 Published:2018-07-20

Abstract: Objective To investigate the clinical characteristics, imaging features, diagnosis, and treatment of low-grade myofibroblastic sarcoma(LGMS)of the head and neck. Methods A retrospective study of 2 patients with LGMS of the head and neck was performed, and previous cases of LGMS affecting the head and neck reported in the literature were reviewed. The clinic-pathological characteristics, imaging features, diagnosis and treatment were recorded. Results The symptoms of LGMS depend on the location of the tumor. Hoarseness is the first symptom of LGMS affecting vocal cord, along with an increase in dyspnea. LGMS of the neck manifests as a painless mass. It has been observed that LGMS of neck manifests as a painless mass with smooth surgace, capsule, and wide base, while its interface is unclear. Computed tomography demonstrated moderate or inhomogeneous density of tumor necrosis. Moreover, the tumor is characterized by calcification, or even bone destruction, and slight uniform ring enhancement. T1W2 weighted MRI showed the tumor with low signal or limited numbers, while in T2W1 weighted phase, homogeneous or inhomogeneous high signal was observed. The tumor consisted of spindle cells and small polygonal cells arranged in bundles, loose, and braided arrangement. The neoplasm showed diffuse infiltrative growth, and could invade the mucosa squamous epithelium. Tumor cells had unclear, fusiform shape, and the nucleus was slender, enlarged, irregular, and hyperchromatic. On immunohistochemistry analysis, the tumor cells were positive for vimentin, SMA, desmin, and actin, but negative for S-100. Treatment methods mainly focus on extensive surgical resection, and in the 2 cases that were followed up for 12-23 months, no recurrence and metastasis were observed. Conclusion LGMS of the head and neck is a very rare tumor, which lacks easily recognizable clinical and imaging manifestations. Pathological diagnosis must be combined with immunohistochemical examination, while extensive resection is the most effective method of treatment. Specifically, a thoroughgoing resection and negative margin are the keys to success of surgery. LGMS of the head and neck is not sensitive to chemotherapy and radiotherapy. Disease prognosis is good, while recurrence depends on complete resection.

Key words: Neoplasm, Pathology, Head and neck, Low-grade myofibroblastic sarcoma, Iconography

CLC Number: 

  • R767.04
[1] Gabbiani G, Majno G. Dupuytrens contracture: fibroblast contraction? An ultrastructural study[J]. Am J Pathol, 1972, 66(1): 131-146.
[2] Vasudev KS, Harris M. A sarcoma of myofibroblasts: an ultrastructural study[J]. Arch Pathol Lab Med, 1978, 102(4):185-188.
[3] Mentzel T, Dry S, Katenkamp D, et al. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors[J]. Am J Surg Pathol, 1998, 22(10):1228-1238.
[4] Fletcher CDM, Unni KK, Mertens F. World Health Organization: classification of tumors. Pathology and genetics of tumors of soft tissue and bone[M]. IARC Press: Lyon, 2002, 47:91-95.
[5] Fisher C. Myofibrosarcoma[J]. Virchows Arch, 2004, 445(3):215-223.
[6] Huang SH, O'Sullivan B. Overview of the 8th edition tnm classification for head and neck cancer[J]. Curr Treat Options Oncol, 2017, 18(7):40.
[7] Farhood AI, Hajdu SI, Shiu MH, et al. Soft tissue sarcomas of the head and neck in adults[J]. Am J Surg, 1990, 160:365-369.
[8] Covello R, Licci S. Low-grade myofibroblastic sarcoma of the larynx[J]. Int J Surg Pathol, 2011, 19(6):822-826.
[9] Montgomery E, Goldlum JR, Fisher C. Myofibrosarcoma: a clinicopathologic study[J]. Am J Surg Pathol, 2001, 25(5):219-228.
[10] Thompson LD, Karamurzin Y, Wu ML, et al. Solitary fibrous tumor of the larynx[J]. Head Neck Pathol, 2008, 2(2):67-74.
[11] 张薇薇, 许乙凯. 低度恶性肌纤维母细胞肉瘤的影像学表现[J]. 中国医学影像技术, 2012, 28(8):1591-1595.
[12] Niedzielska I, Janic T, Mrowiec B. Low grade myofibroblastic sarcoma of the mandible: a case report[J]. J Med Case Rep, 2009, 3:8458.
[13] 方三高,肖薇,肖华亮,等. 喉低级别肌纤维母细胞肉瘤临床病理观察[J]. 诊断病理学杂志, 2012, 19(5):377-380.
[14] Kordac P, Nikolov DH, Smatanova K, et al. Low-grade myofibroblastic sarcoma of the larynx:case report and review of literature[J]. Acta Medica, 2014, 57(4):162-164.
[15] Ni C, Xu YY, Zhou SH, et al. Differential diagnosis of inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: two cases reports with a literature review[J]. J Int Med Res, 2011, 39(1):311-320.
[16] Thompson LD, Wieneke JA, Miettinen M, et al. Spindle cell(sarcomatoid)carcinomas of the larynx: a clinicopathologic study of 187 cases[J]. Am J Surg Pathol, 2002, 26(2):153-170.
[17] Watanabe K, Ogura G, Tajino T, et al. Myofibrosarcoma of the bone: a clinicopathologic study[J]. Am J Surg Pathol, 2001, 25(12):1501-1507.
[18] Demarosi F, Bay A, Moneghini L, et al. Low-grade myofibroblastic sarcoma of the oral cavity[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 108(2):248-254.
[19] Jay A, Piper K, Farthing PM, et al. Low-grade myofibroblastic sarcoma of the tongue[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104(5):52-58.
[1] LIU Jiahui, TIAN Ruxian, LI Yumei, SONG Xicheng. Construct of a cuproptosis-related lncRNA model to predict prognosis in head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 49-64.
[2] PENG Zhonghua, CHEN Zhu, YUAN Luohua, YU Shaolan, MA Yuling. Primary high-grade non-intestinal-type adenocarcinoma of the nasal cavity: a case report and review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 95-98.
[3] CHENG Zhuo, LIANG Hui, XING Lumin. Research progress and prospect analysis of deep learning technology in the application of pharyngeal and laryngeal endoscopy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 112-119.
[4] PAN Linlin, WAN Jiaming, LI Yue, HE Long. Autophagy-related long noncoding RNA is a prognostic indicator for head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 97-107.
[5] YIN Zhenqian, HUANGFU Hui. Kimura disease:a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 104-107.
[6] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[7] SHI Jinlian, LI Jianxing, HUANG Yousheng, LIN Mingxuan, LIU Lingyun, LU Yongtian. Research status and progress in diagnosis and treatment of laryngeal inflammatory myofibroblastic tumor [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 186-192.
[8] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[9] XIE Feng, XU Zhenju, WU Ce, LIU Jie, ZANG Chuanshan, ZHANG Longxiao, HAN Min. Clinicopathologic and survival analysis of laryngeal neuroendocrine neoplasm in 26 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 79-86.
[10] HUANG Jiali, LIU Ziqi, XU Juan, CHEN Xi, ZHANG Liqing, ZHOU Han. Clinical and prognostic analysis of spindle cell squamous carcinoma of pharynx [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 94-100.
[11] LI Dou, SUI Xinke, YANG Xiaoman, GUO Hongyuan, WANG Min, ZHONG Changqing, LI Lianyong. Changes in endoscopic and pathological indices of the lower oesophageal mucosa in patients with simple pharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 85-90.
[12] JIN Peng, LIANG Xu, WANG Yang, ZI Xiaoxue. An exploration of PBL combined with CBL and CPTM methods in clinical teaching of otorhinolaryngology head and neck surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 70-76.
[13] ZHANG Jingyi, DONG Xiangyi, MU Yakui, SONG Xicheng. Research progress on pyroptosis in otorhinolaryngology diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 140-148.
[14] XIE Yulin, LEI Dapeng. Advances in the pathological study of artificial intelligence in the lymph node metastasis of head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 124-129.
[15] LI Baofei, AINIWAER·Mailudan, YANG Xin, CHEN Fei. The application of adipofascial anterolateral thigh flap in reconstruction of the head and neck [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 87-91.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!